Rational approaches towards inorganic and organometallic antibacterials

2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Jeannine Hess

Abstract The occurrence of drug-resistant bacteria is drastically rising and new and effective antibiotic classes are urgently needed. However, most of the compounds in development are minor modifications of previously used drugs to which bacteria can easily develop resistance. The investigation of inorganic and organometallic compounds as antibiotics is an alternative approach that holds great promises due to the ability of such molecules to trigger metal-specific mechanisms of action, which results in lethal consequences for pathogens. In this review, a selection of concepts to rationally design inorganic and organometallic antibiotics is discussed, highlighting their advantages by comparing them to classical drug discovery programmes. The review concludes with a short perspective for the future of antibiotic drug development and the role metal-based compounds will play in the field.

2018 ◽  
Vol 107 ◽  
pp. 279-284
Author(s):  
Pankaj Kumar Roy ◽  
M. Ghosh ◽  
M. Biswas Roy

Author(s):  
Katya B. Popova ◽  
Aikaterini Valsamatzi-Panagiotou ◽  
Robert Penchovsky

JMS SKIMS ◽  
2014 ◽  
Vol 17 (2) ◽  
pp. 48-49
Author(s):  
Bashir A Fomda

The discovery of penicillin in 1928 by Alexander Fleming , a magic antibiotic used for treatment of most of the bacterial infection marked the beginning of antibiotic era. With booming drug development a new drug was always available to treat increasing drug resistant bacteria. Between 1935 to 2003 fourteen classes of antibiotics were developed. However with the indiscriminate and inappropriate use of antibiotics, microbes developed mechanisms to elude the action of antimicrobial agents. JMS 2014;17(2):48-49


Sign in / Sign up

Export Citation Format

Share Document